Viewing Study NCT05501756


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-01 @ 7:11 PM
Study NCT ID: NCT05501756
Status: RECRUITING
Last Update Posted: 2025-07-17
First Post: 2022-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module